Loading…
The agreement was announced on July 30, 2026.
Mangoceuticals, Inc. (Nasdaq: MGRX) announced a Business Combination Agreement with Nuclea Energy Inc. on July 30, 2026. The agreement outlines the terms and conditions under which the two companies will merge.
Details of the agreement were disclosed in an EDGAR Filing under document number 0001493152-26-035323. The filing indicates that the combination is subject to customary closing conditions, including regulatory approvals and shareholder consents.
As of the announcement, Mangoceuticals had a free float of 4,920,547 shares.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.